Use First-Line MS Therapies: Interferons and Glatiramer Acetate to guide the working diagnosis and next step; let the main risk or management issue drive escalation, treatment choice, and follow-up.

These traditional treatments are quite reliable, reducing clinical relapse rates by approximately 30%.; As for contraindications, it is strictly off-limits for anyone with a known hypersensitivity to human albumin.; Interferon beta 1a is derived from mammalian cell lines, which makes it less immunogenic and allows for less frequent dosing intervals.; It mostly comes down to how they are manufactured and dosed.; Glatiramer acetate is a synthetic polymer made up of a specific chain of amino acids that structurally resembles myelin basic protein.